AGOURA HILLS, Calif., June 24, 2013 /PRNewswire/ -- Biozoom (OTC QB: BIZM) creator of the world's first of its kind portable, handheld device for real-time biofeedback, announced today that the device has entered commercial production. "The Biozoom scanner has captured the attention of so many organizations that production has moved from prototype to commercial scale," said Biozoom CTO, Dr. Wolfgang Kocher. The first shipment of scanners is expected to arrive in September. "They will be used to extend our test marketing with key commercial, healthcare and governmental entities."
The Biozoom scanner non-invasively measures and analyzes the biomarkers critical to understanding, managing and improving a user's health and wellness. The prototype units have been validated in clinical trials and used at respected European institutions. The first commercially produced scanners are expected to be used for large-scale studies by major multinational cosmetics and consumer goods producers, as well as large employers.
A portion of the first shipment will be dedicated to market testing in the United States, where health and wellness represent a $150 billion opportunity. "People everywhere want to live longer and healthier lives. A recent study by the Consumer Electronics Association indicated that 55% of online consumers in the US used some form of fitness electronics last year, and 37% anticipate buying a wellness related device this year," said Dr. Kocher.
Biozoom's innovation has been the successful miniaturization of reflection spectroscopy. The development of the biofeedback scanner has its roots in patented optics produced by Carl Zeiss, which overcome the challenges of portable, handheld spectroscopy. At the press of a button, the transdermal scanner collects and sends spectroscopic data to Biozoom's servers, which instantly return both results and wellness support coaching to the user."We have reached an exciting milestone," said CEO Hardy Hoheisel. "The first commercially produced units will include all of the patented components and will prove the feasibility of low-cost mass production." Because the Biozoom scanner measures anti-aging factors including skin moisture and nutritional absorption, "it is of great interest to the cosmetics industry," said Dr. Kocher. "At the same time, the scanner gives new insight into the overall health and wellbeing of users by measuring antioxidant levels, stress responses and much more. Several large organizations have expressed interest in using the scanner to understand and support the health of their employees. By focusing on wellness and disease prevention, they can use Biozoom to help drive down healthcare costs and absenteeism due to preventable illness."
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts